Swedish Orphan Biovitrum Ab (BIOVF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BIOVF | ASND | BPMC | ||
| Company | Swedish Orphan Biovitrum Ab | Ascendis Pharma ADR | Blueprint Medicines Corp | ||
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | ||
| Open | 25.2040 | 135.67 | 116.25 | ||
| High | 25.2040 | 137.62 | 117.20 | ||
| Low | 25.2040 | 134.55 | 114.33 | ||
| Last | 25.2040 | 136.32 | 116.81 | ||
| Change | -1.3060 | +1.11 | +1.84 | ||
| % Change | -4.93% | +0.82% | +1.60% | ||
| Volume | 100 | 342,259 | 603,938 | ||
| 20-Day Average Volume | 665 | 301,788 | 670,617 | ||
| Previous Close | 26.5100 | 135.21 | 114.97 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 26.0083 | 135.92 | 112.79 | ||
| 20-Day Raw Stochastic | 47.44% | 62.82% | 74.70% | ||
| 20-Day Relative Strength | 51.86% | 51.84% | 60.28% | ||
| Weighted Alpha | N/A | +39.58 | +99.86 | ||
| Today's Opinion | N/A | 24% Buy | 100% Buy | ||
| Previous Opinion | N/A | 8% Buy | 96% Buy | ||
| Last Month's Opinion | N/A | 40% Sell | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -4.39% since 06/12/24 | -0.53% since 07/15/24 | -2.28% since 07/15/24 | ||
| Low | 25.2040 on 07/17/24 | 132.59 on 07/19/24 | 109.50 on 07/18/24 | ||
| High | 27.5369 on 06/25/24 | 142.21 on 07/16/24 | 121.90 on 07/16/24 | ||
| 1-Month | |||||
| %Chg | -4.28% since 06/13/24 | +6.62% since 06/21/24 | +12.07% since 06/21/24 | ||
| Low | 25.2040 on 07/17/24 | 126.37 on 06/24/24 | 101.78 on 06/24/24 | ||
| High | 27.5369 on 06/25/24 | 142.21 on 07/16/24 | 121.90 on 07/16/24 | ||
| 3-Month | |||||
| %Chg | +0.82% since 04/01/24 | -4.07% since 04/22/24 | +28.92% since 04/22/24 | ||
| Low | 22.8700 on 04/18/24 | 116.63 on 05/14/24 | 88.46 on 04/25/24 | ||
| High | 27.5369 on 06/25/24 | 147.45 on 04/23/24 | 121.90 on 07/16/24 | ||
| 6-Month | |||||
| %Chg | -6.65% since 01/10/24 | +1.61% since 01/22/24 | +40.70% since 01/22/24 | ||
| Low | 22.8700 on 04/18/24 | 116.63 on 05/14/24 | 72.24 on 02/14/24 | ||
| High | 27.7900 on 03/12/24 | 161.00 on 02/26/24 | 121.90 on 07/16/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 7,439,213 | 7,873,413 | 7,199,077 | ||
| Shares Outstanding, K | 295,160 | 58,231 | 62,617 | ||
| Annual Sales | 2,086,200,000 | 288,670,000 | 249,380,000 | ||
| Annual Net Income | 227,170,000 | -521,070,000 | -506,980,000 | ||
| Last Quarter Sales | 601,200,000 | 104,110,000 | 96,120,000 | ||
| Last Quarter Net Income | 76,880,000 | -142,260,000 | 89,140,000 | ||
| 60-Month Beta | 0.59 | 0.63 | 0.63 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.07 on 07/16/24 | -2.48 on 05/02/24 | -1.32 on 05/02/24 | ||
| Latest Earnings Date | 07/16/24 | 09/03/24 | 08/01/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 38.99 | 0.00 | 0.00 | ||